approx 6 months to go, page-3

"Also Rob why would they want to diversify at this stage"

ahjay, I tend to agree with your sentiment, but for a rare moment, let me play the devils advocate.

Some could view the diversification as a move in an another direction because the ovarian trials are not going as well as expected - otherwise, why divert resources from something which is supposedly progressing well. If its progressing so well why not concentrate 100% on ovarian for now??????

I wish I had the answer for the diversification at this stage in the cycle.

However, as I said earlier, the speed or lack of speed in the Canvas 3 recruitment will give a clue. We need to keep an eye on recruitment activity.